Meetings and events

Research meetings 

Below is a list of our upcoming research meetings. These research meetings are aimed at Cochrane members interested in activities at Cochrane Denmark and healthcare research. The meetings are also open to external researchers, students and healthcare professionals. 


  

THIS RESEARCH MEETING IS CANCELLED AND WILL BE RESCHEDULED FOR 2021

Conflicts of interest in research

Findings from medical research studies, such as randomised trials and systematic reviews, have a profound impact on patient care. It is therefore essential, that such studies are trustworthy. Quite often, medical research is either funded by drug or device companies or written by authors that have ties with individual companies; for example by being on a company’s speakers’ bureau or advisory board. Such relationships create conflicts of interest. It is an ongoing concern whether conflicts of interest impact medical research and consequently on patient care.
The topic of the talk will be to describe drug and device industry influences on research. Camilla will present findings on how conflicts of interest impact on 1) systematic reviews, 2) non-primary research studies such as clinical guidelines, committee meetings, opinion pieces (e.g. editorials), and non-systematic reviews, and 3) randomised trials.

About the presenter
Camilla Hansen is a PhD Student at Centre for Evidence-Based Medicine Odense (CEBMO) at Odense University Hospital and the University of Southern Denmark and a research coordinator for the Cochrane Bias Methods Group. She has a master's degree in science of public health.

When:
18th September at 10 am - 11 am CANCELLED
Who can attend: 
The research meeting is aimed for all employees at Cochrane Denmark, in Cochrane review groups and external researchers and students interested in healthcare research. 
Where:
To be updated soon
How to register:




THIS RESEARCH MEETING IS CANCELLED AND WILL BE RESCHEDULED FOR 2021

The new Cochrane risk of bias tool (RoB2) to assess risk of bias in randomized trials

A good systematic review synthesizes results of unbiased studies. If included studies are biased; however, the review risks presenting a summary estimate that is statistically precise, and therefore often perceived as trustworthy, but which systematically deviates from the truth.
The most frequently used tool to assess risk of bias in randomized trial is the Cochrane risk of bias tool, which was published in a revised version in 2019, RoB2. Professor Asbjørn Hróbjartsson will present the various meanings of the term ‘bias’, and relate the concept to statistical precision and heterogeneity, provide an overview of the main new aspects of RoB2, and discuss the strengths and weaknesses of how risk of bias in included trials is conducted in current reviews.

About the presenter
Asbjørn Hróbjartsson is a professor and head of research at the Centre for Evidence-Based Medicine Odense (University of Southern Denmark), and co-convenor of the Cochrane Bias Methods Group.

When:
2nd December 2020 - 1pm CANCELLED
Who can attend:
The research meeting is aimed for all employees at Cochrane Denmark, Cochrane members, external researchers and students interested in healthcare research
Where:
To be updated soon
How to register: